Elena Schneider-Futschik laboratory

Research Overview

View Dr Schneider Futschik's latest PubMed publications listing here.


Photo of the Schneider-Futschik lab

Cystic fibrosis (CF) is a life limiting disease caused by defective or deficient cystic fibrosis trans-membrane conductance regulator (CFTR) activity. The recent approval of CFTR modulator drugs targets the majority of CF patients with a certain CFTR-mutation.

Our innovative research program seeks to identify how these drugs move (pharmacokinetics, PK), work (pharmacodynamics, PD) and interact in the human body, and uses this information to optimise efficacy.

Our inter-linked research themes are:

  1. Understanding the treatment challenges associated with drug-drug interactions in cystic fibrosis and characterising the PK/PD of CFTR modulators and their metabolites
  2. Investigating how the prolonged exposure to bacteria induces tolerance during CFTR modulator therapy in cystic fibrosis.
  3. Understanding the cross-talk between CFTR modulator drugs and antibiotics
  4. Elucidating the exposure of CFTR modulators during pregnancy and breastfeeding


Dr Elena Schneider-Futschik, Group leader
Dr Marsha Tan

Previous Staff

Dr Mao Pu, visiting Postdoctoral researcher
Rafah Allobawi

Current students:

Kiera Harwood (Honours)
XiaoXuan Han Harry (Masters)
Fiona Qiu (PhD, previous Honours)

Previous students:

Drishti Ghelani (Honours)
Fan Frank Chen (Masters)
Adil Hanif (Masters)
Xiaohan Hu (Masters)


Professor John Wilson, The Alfred Hospital

Associate Professor Gauri Rao, UNC

Dr Jane Bourke, Monash University

Professor Gary Anderson, University of Melbourne

Dr William Figgett, Peter Doherty Institute

Dr Felisa Reyes-Ortega, Granada University

Professor Isabelle Sermet-Gaudelus, INSERM Paris

Professor Claire Wainwright, Health QLD

Mrs Clare Walter, Climate Energy College Melbourne

Dr Martin Donnelley (The University of Adelaide)

Associate Professor David Parsons (The University of Adelaide)


2019-2022 NHMRC Peter Doherty Fellowship. Systems pharmacology of cystic fibrosis transmembrane regulator correctors and potentiators. EK Schneider

Research Opportunities

This research project is available to PhD students, Honours students, Master of Biomedical Science to join as part of their thesis.
Please contact the Research Group Leader to discuss your options.

Research Publications

Scientific advocacy

2019: Expert Position Statement on health-based standards for Australian regulated thresholds of nitrogen dioxide, sulfur dioxide and ozone in ambient air. Published: Lung Foundation Australia

Research Projects

This Research Group doesn't currently have any projects

Faculty Research Themes

Infection and Immunology

School Research Themes

Cardio-Respiratory, Therapeutics & Translation

Key Contact

For further information about this research, please contact Head of Laboratory Dr Elena Schneider-Futschik

Department / Centre

Biochemistry and Pharmacology , Lung Health Research Centre

Unit / Centre

Elena Schneider-Futschik laboratory

MDHS Research library
Explore by researcher, school, project or topic.